Total Payments
$3,049
2024 Payments
$433.08
Companies
28
Transactions
160
Medicare Patients
5,239
Medicare Billing
$543,727
Payment Breakdown by Category
Food & Beverage$3,049 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,049 | 160 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $626.12 | 29 | $0 (2024) |
| ABBVIE INC. | $489.38 | 25 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $464.75 | 28 | $0 (2024) |
| Lilly USA, LLC | $197.61 | 9 | $0 (2024) |
| Abbott Laboratories | $176.34 | 9 | $0 (2023) |
| Novo Nordisk Inc | $148.62 | 7 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $116.61 | 6 | $0 (2021) |
| IDORSIA PHARMACEUTICALS US INC | $108.11 | 5 | $0 (2023) |
| PFIZER INC. | $101.72 | 5 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $61.56 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $433.08 | 19 | Amgen Inc. ($217.87) |
| 2023 | $658.96 | 34 | Amgen Inc. ($153.73) |
| 2022 | $437.36 | 20 | ABBVIE INC. ($176.73) |
| 2021 | $783.98 | 42 | Takeda Pharmaceuticals U.S.A., Inc. ($203.39) |
| 2020 | $434.68 | 21 | Takeda Pharmaceuticals U.S.A., Inc. ($87.62) |
| 2019 | $111.81 | 9 | Teva Pharmaceuticals USA, Inc. ($33.84) |
| 2018 | $69.98 | 6 | Takeda Pharmaceuticals U.S.A., Inc. ($27.07) |
| 2017 | $118.86 | 9 | Takeda Pharmaceuticals America, Inc. ($45.08) |
All Payment Transactions
160 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: VACCINES | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | ALK-Abello, Inc | Odactra (Drug), Grastek, Ragwitek | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Allergy and Immunology | ||||||
| 09/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $32.77 | General |
| Category: Inflammation | ||||||
| 07/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: Inflammation | ||||||
| 07/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: Diabetes | ||||||
| 05/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $29.67 | General |
| Category: Inflammation | ||||||
| 04/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $32.27 | General |
| Category: Bone Health | ||||||
| 04/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: Inflammation | ||||||
| 03/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $33.24 | General |
| Category: Bone Health | ||||||
| 02/21/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: Obesity | ||||||
| 02/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Inflammation | ||||||
| 01/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $31.67 | General |
| Category: Bone Health | ||||||
| 01/02/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Oncology | ||||||
| 12/27/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/13/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $32.03 | General |
| Category: Bone Health | ||||||
| 11/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/17/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $31.78 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,348 | 2,617 | $269,734 | $140,242 |
| 2022 | 18 | 1,254 | 2,494 | $265,645 | $137,659 |
| 2021 | 20 | 1,361 | 2,799 | $269,319 | $144,411 |
| 2020 | 20 | 1,276 | 2,807 | $268,435 | $121,416 |
Total Patients
5,239
Total Services
10,717
Medicare Billing
$543,727
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 289 | 711 | $124,425 | $70,764 | 56.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 304 | 515 | $77,250 | $36,046 | 46.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 116 | 116 | $17,400 | $10,022 | 57.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 27 | $5,400 | $3,729 | 69.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 18 | 38 | $5,700 | $3,718 | 65.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $5,850 | $3,203 | 54.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 86 | 227 | $8,626 | $2,594 | 30.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 17 | 17 | $2,601 | $2,360 | 90.7% |
| 99423 | Online digital evaluation and management service for an established patient for up to 7 days, total time 21 or more minutes | Office | 2023 | 30 | 60 | $5,280 | $2,259 | 42.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 37 | 62 | $3,760 | $2,181 | 58.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 64 | 68 | $4,420 | $751.80 | 17.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 143 | 197 | $1,182 | $668.36 | 56.5% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 30 | 32 | $1,280 | $525.52 | 41.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 13 | $481.00 | $429.65 | 89.3% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 12 | 13 | $520.00 | $424.21 | 81.6% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 23 | 26 | $1,040 | $208.50 | 20.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 16 | 20 | $600.00 | $168.00 | 28.0% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 35 | 198 | $1,944 | $83.15 | 4.3% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 32 | 128 | $1,280 | $51.17 | 4.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 14 | 45 | $675.00 | $51.11 | 7.6% |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | Office | 2023 | 18 | 78 | $19.50 | $5.75 | 29.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 304 | 770 | $134,750 | $76,118 | 56.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 287 | 514 | $77,100 | $35,687 | 46.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 134 | 134 | $20,100 | $11,287 | 56.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 23 | 23 | $3,519 | $3,282 | 93.3% |
About Dr. Nhat Vo, M.D
Dr. Nhat Vo, M.D is a Internal Medicine healthcare provider based in Moorpark, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1215924451.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nhat Vo, M.D has received a total of $3,049 in payments from pharmaceutical and medical device companies, with $433.08 received in 2024. These payments were reported across 160 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($3,049).
As a Medicare-enrolled provider, Vo has provided services to 5,239 Medicare beneficiaries, totaling 10,717 services with total Medicare billing of $543,727. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pediatrics
- Location Moorpark, CA
- Active Since 10/03/2005
- Last Updated 11/14/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1215924451
Products in Payments
- TRINTELLIX (Drug) $420.50
- VRAYLAR (Drug) $283.87
- Otezla (Drug) $220.11
- Aimovig (Biological) $203.44
- QULIPTA (Drug) $180.74
- EVENITY (Biological) $160.99
- QUVIVIQ (Drug) $108.11
- Ozempic (Drug) $104.37
- Trintellix (Drug) $89.33
- JARDIANCE (Drug) $88.82
- FARXIGA (Drug) $82.97
- FREESTYLE LIBRE 2 (Device) $73.23
- Kerendia (Drug) $61.56
- AJOVY (Drug) $53.17
- TRULICITY (Drug) $52.46
- FreeStyle Libre 2 (Device) $52.28
- FREESTYLE LIBRE 3 (Device) $50.83
- UBRELVY (Drug) $43.92
- PREVNAR 20 (Biological) $43.78
- Odactra (Drug) $42.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.